213 related articles for article (PubMed ID: 37204788)
21. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study.
Gaussoin SA; Pajewski NM; Chelune G; Cleveland ML; Crowe MG; Launer LJ; Lerner AJ; Martindale-Adams J; Nichols LO; Ogrocki PK; Sachs BC; Sink KM; Supiano MA; Wadley VG; Wilson VM; Wright CB; Williamson JD; Reboussin DM; Rapp SR
J Am Geriatr Soc; 2022 May; 70(5):1384-1393. PubMed ID: 34826341
[TBL] [Abstract][Full Text] [Related]
22. Association Between the Frailty and Cognitive Impairment Among Patients With Hypertension-A Post Hoc Analysis of the SPRINT Trial.
Wang Z; Wang Q; Pei J; Wang X; Li Y; Yan J; Du X
J Am Heart Assoc; 2023 Apr; 12(7):e028736. PubMed ID: 36974773
[TBL] [Abstract][Full Text] [Related]
23. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
[TBL] [Abstract][Full Text] [Related]
24. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
Oikonomou EK; Spatz ES; Suchard MA; Khera R
Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
[TBL] [Abstract][Full Text] [Related]
25. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
[TBL] [Abstract][Full Text] [Related]
26. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.
; Nasrallah IM; Pajewski NM; Auchus AP; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Doshi J; Erus G; Fine LJ; Gaussoin SA; Harris D; Johnson KC; Kimmel PL; Kurella Tamura M; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB; Williamson JD; Bryan RN
JAMA; 2019 Aug; 322(6):524-534. PubMed ID: 31408137
[TBL] [Abstract][Full Text] [Related]
27. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.
Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM;
JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324
[TBL] [Abstract][Full Text] [Related]
28. Association Between Baseline Diastolic Blood Pressure and the Efficacy of Intensive vs Standard Blood Pressure-Lowering Therapy.
Foy AJ; Filippone EJ; Schaefer E; Nudy M; Ruzieh M; Dyer AM; Chinchilli VM; Naccarelli GV
JAMA Netw Open; 2021 Oct; 4(10):e2128980. PubMed ID: 34668944
[TBL] [Abstract][Full Text] [Related]
29. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
30. Association of Estimated Pulse Wave Velocity With Survival: A Secondary Analysis of SPRINT.
Vlachopoulos C; Terentes-Printzios D; Laurent S; Nilsson PM; Protogerou AD; Aznaouridis K; Xaplanteris P; Koutagiar I; Tomiyama H; Yamashina A; Sfikakis PP; Tousoulis D
JAMA Netw Open; 2019 Oct; 2(10):e1912831. PubMed ID: 31596491
[TBL] [Abstract][Full Text] [Related]
31. Intensive Blood Pressure Treatment and Subclinical Brain Infarcts: A Secondary Analysis of SPRINT (Systolic Pressure Intervention Trial).
Kern KC; Nasrallah IM; Bryan RN; Williamson J; Reboussin DM; Pajewski NM; Wright CB
Ann Neurol; 2024 May; 95(5):866-875. PubMed ID: 38362733
[TBL] [Abstract][Full Text] [Related]
32. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
[TBL] [Abstract][Full Text] [Related]
33. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial.
Jiang C; Li S; Wang Y; Lai Y; Bai Y; Zhao M; He L; Kong Y; Guo X; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
Hypertension; 2023 Mar; 80(3):580-589. PubMed ID: 36688305
[TBL] [Abstract][Full Text] [Related]
34. Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events.
Bress AP; Greene T; Derington CG; Shen J; Xu Y; Zhang Y; Ying J; Bellows BK; Cushman WC; Whelton PK; Pajewski NM; Reboussin D; Beddu S; Hess R; Herrick JS; Zhang Z; Kolm P; Yeh RW; Basu S; Weintraub WS; Moran AE;
J Am Coll Cardiol; 2021 Apr; 77(16):1977-1990. PubMed ID: 33888247
[TBL] [Abstract][Full Text] [Related]
35. 24-Hour Blood Pressure Variability Via Ambulatory Monitoring and Risk for Probable Dementia in the SPRINT Trial.
Sible IJ; Nation DA
J Prev Alzheimers Dis; 2024; 11(3):684-692. PubMed ID: 38706284
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
Still CH; Rodriguez CJ; Wright JT; Craven TE; Bress AP; Chertow GM; Whelton PK; Whittle JC; Freedman BI; Johnson KC; Foy CG; He J; Kostis JB; Lash JP; Pedley CF; Pisoni R; Powell JR; Wall BM;
Am J Hypertens; 2017 Dec; 31(1):97-107. PubMed ID: 28985268
[TBL] [Abstract][Full Text] [Related]
37. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial.
Obi Y; Kalantar-Zadeh K; Shintani A; Kovesdy CP; Hamano T
J Intern Med; 2018 Mar; 283(3):314-327. PubMed ID: 29044764
[TBL] [Abstract][Full Text] [Related]
38. Estimated Pulse Wave Velocity and Cognitive Outcomes: A Post hoc Analysis of SPRINT-MIND.
Hao P; Feng S; Suo M; Wang S; Zheng K; Wu X
Am J Hypertens; 2024 Jun; 37(7):485-492. PubMed ID: 38488616
[TBL] [Abstract][Full Text] [Related]
39. Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial.
Kurella Tamura M; Gaussoin SA; Pajewski NM; Chelune GJ; Freedman BI; Gure TR; Haley WE; Killeen AA; Oparil S; Rapp SR; Rifkin DE; Supiano M; Williamson JD; Weiner DE;
J Am Soc Nephrol; 2020 Sep; 31(9):2122-2132. PubMed ID: 32591439
[TBL] [Abstract][Full Text] [Related]
40. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
